Zoledronic Acid News and Research

RSS
Zoledronic acid is a drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with other drugs to treat multiple myeloma and to prevent bone fractures and reduce bone pain in people who have cancer that has spread to the bone. It is a type of bisphosphonate. Also called zoledronate and Zometa.
Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosis

Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosis

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Zometa reduces bone loss in patients receiving breast cancer treatment

Zometa reduces bone loss in patients receiving breast cancer treatment

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

First filing for zoledronic acid in metabolic bone disease

First filing for zoledronic acid in metabolic bone disease